{"prompt": "['APPROVED:', 'Jun 23, 2017', 'copernicus', 'COPERNICUS GROUP IRB', 'group', 'independent', 'review board', 'Approved:', 'could order medical records shown to other people, but that is unlikely. Therefore,', 'should this scenario occur, full confidentiality cannot be guaranteed.', \"Adverse event reporting: As part of Adelphi Values' agreement with the study sponsor\", '(GlaxoSmithKline), if during the interviews you mention a bad effect/problem that you', 'have experienced while using a product made by GlaxoSmithKline, Adelphi Values', 'must report this back to them. This is so they can monitor and learn more about the', 'safety of their medicines. By consenting to take part in this study you agree to such', 'information being passed on to the sponsor anonymously. You will be identified only by', 'a study participant number.', 'What are the risks or discomforts of the study?', 'There is no risk of physical harm directly related to completing an interview as part of', 'this study. There is the potential risk of loss of confidentiality should you opt to take part', \"in the video task as part of the app task which is explained in the section: 'How will my\", \"information be protected?'\", 'Are there any benefits?', 'You will have no direct medical benefit from your participation in this study. Participation', 'in the study will contribute to information about the experience of nasal polyps, the', 'suitability of the reviewed questionnaires for use in clinical trials and may benefit others', 'in the future.', 'Will I be paid to take part?', 'You will receive $200 upon completion of the 120-minute interview. If you chose to take', 'part in the optional app task, you will receive an additional payment of $200.', 'Payments will be paid by electronic bank transfer or amazon voucher.', 'Are there any costs?', 'You will not incur any costs to take part in this study. If you take part in the optional app', 'task, you may incur data usage charges when downloading/uploading data. We', \"recommend setting your device to 'WiFi only' if you are concerned about using your\", 'mobile data allowance. Submitting your responses by WiFi will be free of charge and', 'not use your data allowance.', 'What are the alternatives?', 'You do not have to take part in this research study.', 'What if I am hurt or get sick in the study?', 'If you are hurt or get sick during the study, you should call your doctor. Neither', 'GlaxoSmithKline nor Adelphi Values have a program in place to provide other', 'compensation in the event of an injury. Since this is a telephone interview, there is no', 'risk of injury. No risks are associated with the app-task; however, it is expected that', 'participants will be sensible when completing and submitting tasks required and that', 'GK7818Av7_0', 'Page 51 of 131', 'Effective: 20 Jan 2017']['APPROVED:', 'Jun 23, 2017', 'copernicus', 'COPERNICUS GROUP IRB', 'group independent review board', 'Approved:', 'these are done in a safe environment, thus reducing any possibility of risk. Participating', 'in this study does not restrict your right to seek legal assistance. You do not waive any', 'legal rights by signing this Subject Information and Consent Form and HIPAA', 'Authorization.', 'Do I have to take part in the study?', 'Taking part in this study is your choice. There will not be any penalty or loss of benefits', 'to you if you decide not to take part or if you leave the study early.', 'Could I be withdrawn from the study?', 'Your doctor or the study sponsor, may withdraw you from the study without your', 'consent for the following reasons:', 'if you do not follow the study procedures as instructed,', 'if the study is canceled by the FDA or the sponsor.', 'The sponsor, the FDA or the IRB may decide to stop the study at any time.', 'You may leave the study at any time.', 'Who can answer my questions about this research?', 'If you have questions, concerns, or complaints, or think this research has hurt you or', 'made you sick, talk to the research team at the phone number listed above on the first', 'page.', 'Please call Copernicus Group IRB at', 'PPD', '(toll free) if:', 'You want to talk to someone about the study other than the study staff;', 'You cannot reach the research team;', 'You have questions about your rights as a research subject.', 'GK7818Av7_0', 'Page 52 of 131', 'Effective: 20 Jan 2017']\n\n###\n\n", "completion": "END"}